Regulatory Updates
🇺🇸 FDA Page 30FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 349–360 of 373 articles
FDA Approves Revitan Gene Therapy for SMA Type 3: Key Details
FDA Approval Mito-X: Accelerated Approval for Advanced Mitochondrial Disease
FDA Approves RenalProtect for Diabetic Kidney Disease Treatment
ThinkTrends AI Platform Deployed by Federal Health Agency for Nationwide Adverse Event Monitoring System
FDA Approves MigraEase: Faster Relief Migraine Drug Launch
FDA Approves NeuroVance XR: New Pediatric ADHD Extended-Release Option
FDA Blockchain Pilot Program: Enhancing Pharmaceutical Supply Chain Security
FDA to Launch AI-Powered Drug Review System by 2027
FDA Approves RenoProtect: New Therapy to Slow Diabetic Kidney Disease
FDA Approves ArterioFlow: Minimally Invasive PAD Treatment by CardioMed
FDA Breakthrough Therapy TargTex TX202: What You Need to Know
FDA Digital Health Innovation Plan: Impact on SaMD Approvals